Heather Moore
Advertisement
Articles by Heather Moore
15 Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA-Mutated, Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Advanced Breast Cancer Treated With Alpelisib
ByEmily J. Gallagher,Heather Moore,Mario E. Lacouture, MD,Susan F. Dent,Azeez Farooki, MD,Marcus D. Goncalves,Claudine Isaacs, MD,Abigail Johnston,Dejan Juric,Zoe Quandt,Laura Spring,Brian Berman,Melanie Decker,Gabriel N. Hortobagyi, MD, FACP,Benjamin H. Kaffenberger,Bernice Y. Kwong,Timothy Pluard,Ruta Rao, MD,Lee Schwartzberg, MD, FACP,Michael S. Broder
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
3
Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer
4
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
5
